Our Founders

John Kosobucki

John is founder and CEO of OX.DH, a disruptor in the healthcare technology space.  A lifelong technologist with a passion for simplifying complex workflows and data, John has led OX.DH from its very beginning.  John has a proven track record of building successful businesses and management teams that deliver transformational experiences to clients.  Early in his career, John joined a startup which was acquired by SunGard; he stayed on and launched a risk management division, scaling it to over one thousand staff, and generating over £100m in revenues annually.  More broadly, John was a key driver in transitioning a product company to a total solution provider; as CTO of the capital markets software division, he pioneered the transition of traditionally in-house applications to SaaS offerings across broad range of trading, risk management, operations & financial platforms resulting in significant revenue growth and margin expansion. John oversaw datacenters on four continents providing real time trading & risk management services with SLA’s measured in milliseconds.  An investor in several early-stage businesses including emerging healthcare, digital transformation & secure communications, John acts as both as an advisor and as a mentor & executive coach, with the objective of accelerating growth.

John has a degree in Computer Science from Dickinson College.

Enda McVeigh

Enda is Associate Professor in Reproductive Medicine at the University of Oxford. He has successfully developed several start-up companies including Ashdale Care (2002) which became the largest private provider of Residential Children’s Care in Ireland, The Fertility Partnership (2010) which became the biggest provider of IVF in the UK with additional centers in Poland. In 2010 Enda also  established a teaching, research and clinical center in Shanghai as Joint Venture between Oxford University, Tongji University and his IVF company, Oxford Fertility. In 2017 Enda initiated the Oxford University Clinic which formed a Joint Venture with The Mayo Clinic.

Paddy McGuinness

Paddy is an advisor to businesses on resilience, cyber defence, the regulatory environment, and geo-political risk. From 2014-2018 he was the United Kingdom’s Deputy National Security Adviser. Paddy led on the implementation of policies and programs designed to build the UK’s domestic resilience to all hazards and threats. He advised two successive Prime Ministers on UK government policy and decision-making on homeland security issues including national resilience and crisis response, cyber security, counter terrorism, and the UK’s response to action by hostile states and coordinated implementation of those decisions. Prior to this, Paddy was in the Diplomatic Service with leadership roles in the Middle East and Africa, Counter-Terrorism, Counter-Proliferation, and aspects of cyber. He served in British Embassies in Rome, Cairo, Abu Dhabi and Sana’a. Paddy is an adviser to the Brunswick Group, PoolRe, Glasswall Solutions and C5 Strategy and a Commissioner of the Oxford Commission on Elections and Technology. He is Chair of Trustees at St Joseph’s Hospice in Hackney.

Cristóbal Conde

Cris is an active investor in early-stage companies, mentoring management teams to help them scale. Named by Institutional Investor as a Top 50 Technologist and Top 40 Fintech investor globally, he currently serves as senior advisor to Accel and TGP Capital. Previously Cris spent 24 years at SunGard, over ten years as its CEO, taking the company private in a record-breaking $11bn LBO.  He received the Queen’s Award for Innovation for contributions to mobile communications and public safety control rooms and thus helping to save lives, with deployments across public agencies including Police, Fire and Ambulance, the MOD, and the RNLI.